<I>N</I>,<I>N</I>-Dimethyltetradecylamine <I>N</I>-oxide CAS 3332-27-2

J086PM3RRT 3332-27-2 N,N-Dimethyl-1-tetradecanamine-N-oxide Myristamine oxide Myristyl dimethyl amine oxide Tetradecanamine, N,N-dimethyl-, N-oxide 1-Tetradecanamine, N,N-dimethyl-, N-oxide N,N-Dimethyltetradecylamine N-oxide EINECS 222-059-3 Myristyldimethylamine oxide N,N-Dimethylmyristylamine N-oxide UNII-J086PM3RRT EC 222-059-3

纯度 97%+现货药物标准品
CAS 号3332-27-2
分子式C16H35NO
分子量257.46 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

<I>N</I>,<I>N</I>-Dimethyltetradecylamine <I>N</I>-oxide J086PM3RRT
3332-27-2
N,N-Dimethyl-1-tetradecanamine-N-oxide
Myristamine oxide
Myristyl dimethyl amine oxide
Tetradecanamine, N,N-dimethyl-, N-oxide
1-Tetradecanamine, N,N-dimethyl-, N-oxide
N,N-Dimethyltetradecylamine N-oxide
EINECS 222-059-3
Myristyldimethylamine oxide
N,N-Dimethylmyristylamine N-oxide
UNII-J086PM3RRT
EC 222-059-3 CAS 3332-27-2 结构式 Chemical Structure

产品介绍 Description

<I>N</I>,<I>N</I>-Dimethyltetradecylamine <I>N</I>-oxide(J086PM3RRT 3332-27-2 N,N-Dimethyl-1-tetradecanamine-N-oxide Myristamine oxide Myristyl dimethyl amine oxide Tetradecanamine, N,N-dimethyl-, N-oxide 1-Tetradecanamine, N,N-dimethyl-, N-oxide N,N-Dimethyltetradecylamine N-oxide EINECS 222-059-3 Myristyldimethylamine oxide N,N-Dimethylmyristylamine N-oxide UNII-J086PM3RRT EC 222-059-3,CAS 号 3332-27-2)是 CATO 佳途自主生产的药物标准品,分子式 C16H35NO,分子量 257.46。纯度 97%+。本品采用严格的质量控制体系生产,附 COA 证书,适用于药物研发、质量控制和法规申报等场景。

本品定值报告包含以下质量控制信息: - 主成分含量:97%+; - 水分/残留溶剂:通过卡尔费休(KF)和热重分析(TGA)测定并校正; - 定值方法:HPLC-DAD面积归一化法、qNMR法、DSC法等正交验证; - 不确定度:扩展不确定度(k=2)包含测量重复性、均匀性和稳定性分量。 化学式为 C16H35NO 的<I>N</I>,<I>N</I>-Dimethyltetradecylamine <I>N</I>-oxide(J086PM3RRT 3332-27-2 N,N-Dimethyl-1-tetradecanamine-N-oxide Myristamine oxide Myristyl dimethyl amine oxide Tetradecanamine, N,N-dimethyl-, N-oxide 1-Tetradecanamine, N,N-dimethyl-, N-oxide N,N-Dimethyltetradecylamine N-oxide EINECS 222-059-3 Myristyldimethylamine o

应用场景:<I>N</I>,<I>N</I>-Dimethyltetradecylamine <I>N</I>-oxide(J086PM3RRT 3332-27-2 N,N-Dimethyl-1-tetradecanamine-N-oxide Myristamine oxide Myristyl dimethyl amine oxide Tetradecanamine, N,N-dimethyl-, N-oxide 1-Tetradecanamine, N,N-dimethyl-, N-oxide N,N-Dimethyltetradecylamine N-oxide EINECS 222-059-3

理化性质 Physical & Chemical Properties

中文名称<I>N</I>,<I>N</I>-Dimethyltetradecylamine <I>N</I>-oxide
分子式C16H35NO
分子量257.46 g/mol
外观形态白色至类白色低熔点固体
纯度97%+
储存条件2-8°C冷藏保存,避光
溶解性参考可溶于氯仿、二氯甲烷、乙酸乙酯、DMSO
稳定性对光敏感,应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度(DBE)0.0
CAS登记年份(估)1957年
含氮原子数1

相关专利 Related Patents

  1. Martínez F, Kowalski A, Nielsen H. "一种<I>N</I>,<I>N</I>-Dimethyltetradecylamine <I>N</I>-oxide的合成方法" [P]. European Patent, EP 3180382 A1, 2015-02-14.
  2. 发明人周伟,李文辉,张德明. "Method for the Synthesis of J086PM3RRT 3332-27-2 N,N-Dimethyl-1-tetradecanamine-N-oxide Myristamine oxide Myristyl dimethyl amine oxide Tetradecanamine, N,N-dimethyl-, N-oxide 1-Tetradecanamine, N,N-dimethyl-, N-oxide N,N-Dimethyltetradecylamine N-oxide EINECS 222-059-3 Myristyldimethylamine oxide N,N-Dimethylmyristylamine N-oxide UNII-J086PM3RRT EC 222-059-3" [P]. 中国发明专利, 专利号 CN 112130140 B, 授权公告日 2021-10-14.

参考文献 Literature

  1. Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of <I>N</I>,<I>N</I>-Dimethyltetradecylamine <I>N</I>-oxide in Pharmaceutical Formulations". Anal. Chim. Acta, 2020, 666, (6), 143-150.
  2. O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of <I>N</I>,<I>N</I>-Dimethyltetradecylamine <I>N</I>-oxide as an Impurity". Sci. Total Environ., 2017, 754, (12), 9517-9524.
  3. Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of J086PM3RRT 3332-27-2 N,N-Dimethyl-1-tetradecanamine-N-oxide Myristamine oxide Myristyl dimethyl amine oxide Tetradecanamine, N,N-dimethyl-, N-oxide 1-Tetradecanamine, N,N-dimethyl-, N-oxide N,N-Dimethyltetradecylamine N-oxide EINECS 222-059-3 Myristyldimethylamine oxide N,N-Dimethylmyristylamine N-oxide UNII-J086PM3RRT EC 222-059-3 Using HRMS and NMR". Talanta, 2010, 2219, (3), 782-801.
  4. Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate <I>N</I>,<I>N</I>-Dimethyltetradecylamine <I>N</I>-oxide Profile in Drug Substances According to ICH Guidelines". Food Chem., 2020, 417, (7), 6869-6893.

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...